Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C129710-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $70.90 | |
C129710-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $319.90 | |
C129710-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $509.90 |
Potent, highly selective GSK3 inhibitor
Synonyms | 252917-06-9|CHIR-99021|CHIR99021|laduviglusib|CHIR 99021|CT99021|CT-99021|6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile|GSK-3 Inhibitor XVI|CHIR-911|6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Product Description | CHIR-99021 (CT99021) HCl is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile |
---|---|
INCHI | InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32) |
InChi Key | AQGNHMOJWBZFQQ-UHFFFAOYSA-N |
Canonical SMILES | CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N |
Isomeric SMILES | CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N |
PubChem CID | 9956119 |
Molecular Weight | 465.34 |
Reaxy-Rn | 25763160 |
Enter Lot Number to search for COA:
Solubility | DMSO 93 mg/mL Water 8 mg/mL Ethanol 2 mg/mL |
---|
Pictogram(s) | GHS06, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H300:Fatal if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
Reaxy-Rn | 25763160 |
1. Saxena M et al.. (2020) A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer.. Cancer Res, 80 (17): (3631-3648). [PMID:32586983] |
2. Fagnocchi L et al.. (2016) A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity.. Nat Commun, 7 (11903). [PMID:27301576] |
3. Balmus G et al.. (2019) ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks.. Nat Commun, 10 (87). [PMID:30622252] |
4. Elling U et al.. (2019) Derivation and maintenance of mouse haploid embryonic stem cells.. Nat Protoc, 14 (7): (1991-2014). [PMID:31160788] |
5. Jeziorowska D et al.. (2017) Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.. Int J Mol Sci, 18 (6): [PMID:28587156] |
6. Song J & Millman JR. (2016) Economic 3D-printing approach for transplantation of human stem cell-derived ß-like cells.. Biofabrication, 9 (015002). [PMID:27906687] |
7. Dole NS et al.. (2021) Mechanosensitive miR-100 coordinates TGFβ and Wnt signaling in osteocytes during fluid shear stress.. FASEB J, 35 (10): (e21883). [PMID:34569659] |
8. Sato H et al.. (2016) Microfabric Vessels for Embryoid Body Formation and Rapid Differentiation of Pluripotent Stem Cells.. Sci Rep, 6 (31063). [PMID:27507707] |
9. Hall AE et al.. (2022) RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer.. Nat Commun, 13 (2791). [PMID:35589755] |